Duyuru • Jun 10
Applied UV, Inc. Bankruptcy Case Dismissed The US Bankruptcy Court dismissed the Chapter 11 case of Applied UV, Inc. on June 9, 2025. The case was dismissed based on the motion filed by Applied UV, Inc. and Sterilumen, Inc. on May 2, 2025. Duyuru • Nov 06
Motion for Asset Sale Filed by Applied UV, Inc. Applied UV, Inc. filed a motion in the US Bankruptcy Court for the sale of its certain assets on November 4, 2024. The debtor seeks the Court’s approval for the sale of its certain assets to the winning bidder at the auction with Auction Advisors LLC as its auctioneer with a commission equal to 10% of the purchase price. The debtor’s assets include Sterilumen’s remaining assets which consists of accounts receivables and physical inventory. To qualify as a qualified bidder, interested parties should submit their bids by January 2, 2025, along with good-faith deposit in the amount of 5% of the bid price. The initial minimum overbid should be at least $0.05 million more than the initial purchase price. The debtor has scheduled an auction on January 8, 2025. At the auction, the subsequent bids would be in increments of $0.05 million. Duyuru • Jul 10
Motion for Asset Sale Filed by Applied UV, Inc. Applied UV, Inc filed a motion in the US Bankruptcy Court for the sale of certain assets on July 8, 2024. The debtor seeks the Court’s approval for the sale of shares of Munn Works held by Applied UV to Mirror Acquisition Corp. for a purchase price of $0.75 million and Sterilumen’s “replacement part” division of its business to KES Technologies, LLC for a purchase price of $0.90 million. To qualify as a qualified bidder, interested parties should submit their bids by September 5, 2024. The initial minimum overbid should be in the amount of at least $0.93 million for the Sterilumen Assets and $0.78 million for shares of Munn Works. The debtor has scheduled an auction on September 10, 2024. The stalking horse bidder would be entitled to an expense reimbursement of $0.03 million in case of termination of the asset purchase agreement. The sale hearing is scheduled for July 25, 2024. KES Technologies, LLC is represented by Matt Thiry of Matt Thiry Law, LLC as its legal advisor. Duyuru • Jun 02
The Nasdaq Stock Market LLC Determines Applied UV’s Common Stock to be Delisted from Nasdaq, as a Result of the Filings of the Chapter 11 Cases On May 24, 2024, Applied UV, Inc. (the ‘Company’), and its wholly owned subsidiary, SteriLumen, Inc. (‘SteriLumen’), filed voluntary petitions for relief under chapter 11 of title 11 of the United States Bankruptcy Code (the ‘Bankruptcy Code’) in the United States Bankruptcy Court for the District of New York (the ‘Bankruptcy Court’). The Company’s and SteriLumen’s chapter 11 cases (the ‘Chapter 11 Cases’) are being administered under the captions In re: Applied UV, Inc., Case No. 24-22462 and In re: Sterilumen, Inc., Case No. 24-22463, respectively. The Company and SteriLumen continue to operate their businesses as a ‘debtor-in-possession’ under the jurisdiction of the Bankruptcy Court and in accordance with the applicable provisions of the Bankruptcy Code and orders of the Bankruptcy Court. The Company and SteriLumen are seeking approval of a variety of ‘first day’ motions containing customary relief intended to enable the Company and SteriLumen to continue their ordinary course operations during the Chapter 11 Cases. The Company and SteriLumen intend to use available cash on hand, which stands at approximately $10,000 and $55,000, respectively, as of the filing date, to fund post-petition operations and costs in the ordinary course. On May 24, 2024, the Company received written notice (the ‘Delisting Notice’) from the staff of The Nasdaq Stock Market LLC (‘Nasdaq’) notifying the Company that, as a result of the filings of the Chapter 11 Cases and in accordance with Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1, the staff of Nasdaq had determined that the Company’s common stock and Series A Preferred Stock will be delisted from Nasdaq. In the Delisting Notice, the staff of Nasdaq referenced the Chapter 11 Filing and associated public interest concerns raised by it, concerns regarding the residual equity interest of the existing listed securities holders and concerns about the Company’s ability to sustain compliance with all requirements for continued listing on Nasdaq. The Delisting Notice also indicates that the Company may appeal Nasdaq’s determination pursuant to procedures set forth in Nasdaq Listing Rule 5800 Series. The Company does not intend to appeal this determination. Trading of the Company’s common stock and Series A Preferred Stock will be suspended at the opening of business on June 4, 2024 and a Form 25-NSE will be filed with the Securities and Exchange Commission, which will remove the Company’s common stock and Series A Preferred Stock from listing and registration on Nasdaq. Duyuru • May 31
Applied UV, Inc.(OTCPK:AUVI.Q) dropped from S&P TMI Index Applied UV, Inc.(OTCPK:AUVI.Q) dropped from S&P TMI Index Duyuru • May 30
Applied UV, Inc.(OTCPK:AUVI.Q) dropped from NASDAQ Composite Index Applied UV, Inc. has been removed from NASDAQ Composite Index . Duyuru • May 26
Applied UV, Inc. Filed for Bankruptcy Applied UV, Inc along with its one affiliate, filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the Southern District of New York on May 24, 2024. The debtor listed its assets in the range of $0.50 million to $1 million and liabilities in the range of $1 million to $10 million. The debtor is represented by Erica Feynman Aisner of Kirby Aisner & Curley LLP as its legal counsel. Duyuru • May 23
Applied UV Receives Letter from Nasdaq Regarding Non-Compliance with Minimum Closing Bid Price Requirement for Continued Listing on the Nasdaq Capital Market Pursuant to Nasdaq Listing Rule 5550(a)(2) On May 16, 2024, Applied UV, Inc. (the ‘Company’) received a letter from the Nasdaq Listing Qualifications Staff of The Nasdaq Stock Market LLC (‘Nasdaq’) therein stating that for the 31 consecutive business day period between April 3, 2024 through May 15, 2024, the common stock of the Company had not maintained a minimum closing bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the ‘Bid Price Rule’). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided an initial period of 180 calendar days, or until November 12, 2024 (the ‘Compliance Period’), to regain compliance with the Bid Price Rule. If the Company does not regain compliance with the Bid Price Rule by November 12, 2024, the Company may be eligible for an additional 180-day period to regain compliance. To qualify, the Company would be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the Bid Price Rule, and would need to provide written notice of its intention to cure the bid price deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If the Company cannot regain compliance during the Compliance Period or any subsequently granted compliance period, the common stock of the Company will be subject to delisting. At that time, the Company may appeal the delisting determination to a Nasdaq hearings panel. The notice from Nasdaq has no immediate effect on the listing of the Company’s common stock and its common stock will continue to be listed on The Nasdaq Capital Market under the symbol ‘AUVI.’ The Company is currently evaluating its options for regaining compliance. There can be no assurance that the Company will regain compliance with the Bid Price Rule or maintain compliance with any of the other Nasdaq continued listing requirements. Duyuru • Mar 28
Applied UV, Inc. has filed a Follow-on Equity Offering in the amount of $2.763 million. Applied UV, Inc. has filed a Follow-on Equity Offering in the amount of $2.763 million.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 1,726,875
Price\Range: $1.6
Security Name: Pre-Funded Warrants
Security Type: Equity Warrant
Transaction Features: Registered Direct Offering Duyuru • Feb 17
Applied UV, Inc. Appoints Christopher Kobucha as Member of the Board Applied UV, Inc. announced On February 14, 2024, the Board appointed Christopher Kobucha, as a member of the Board, effective as of February 14, 2024. Duyuru • Jan 12
Applied UV Inc. Announces Launch of Patented Fighter Flex LED Solution Opening Significant Revenue Opportunity Applied UV Inc. announced the launch of its groundbreaking Fighter Flex LED solution at the upcoming AHR Expo on January 22nd. This disruptive technology is set to redefine energy efficiency in heating, ventilation, and air conditioning (HVAC) systems across the industry. Applied UV Inc. is finalizing distribution agreements with several major international smart building technology brands. The Fighter Flex LED technology was selected by the GSA and DOE for the GSA Green Proving Ground Program. In the United States, office spaces typically require between 50,000 to 75,000 BTUs per year per square foot for heating, influenced by factors such as building age, insulation quality, and local climate. For a standard office building in a moderate climate, air conditioning costs alone can reach approximately $2-$3 per square foot annually. Utilizing patented UVC LED system to maintain the efficiency of HVAC coils has proven to reduce energy consumption by 5-15%. For an owner of a 100,000 square foot office space, the integration of UVC technology could equate to approximately $45,000 in energy savings in the first year alone. The LED Revolution in HVAC Systems Applied UV Inc.'s patented UVC LED fixtures offer a refined alternative to traditional mercury vapor UVC bulbs. fixtures deliver targeted UVC illumination, avoiding wastage on non-essential surfaces, and provide precise dosing control. The switch to UVC LED fixtures from mercury vapor tubes (a 100-year-old technology) can result in an additional 100% increase in energy savings within the UV system, leading to on average an additional $10,000 in annual savings for a 100,000 square foot property. Sustainability Meets Innovation The Fighter Flex LED solution boasts durable, low-maintenance, and mercury-free emitters, marking a significant advancement in UVC LED technology. Applied UV Inc.'s commitment to innovation has been recognized with a major federal agency initiating a full trial of their patent-pending UVC LED design, signifying a transformative step in UV application for coil cleaning within building HVAC systems. Duyuru • Nov 16
Applied UV, Inc. has completed a Composite Units Offering in the amount of $6.4 million. Applied UV, Inc. has completed a Composite Units Offering in the amount of $6.4 million.
Security Name: Units
Security Type: Equity/Derivative Unit
Securities Offered: 42,666,666
Price\Range: $0.15
Discount Per Security: $0.012 Duyuru • Nov 15
Applied UV, Inc. announced delayed 10-Q filing On 11/14/2023, Applied UV, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. New Risk • Nov 15
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$9.7m free cash flow). Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 72% per year over the past 5 years. Shareholders have been substantially diluted in the past year (295% increase in shares outstanding). Market cap is less than US$10m (US$2.73m market cap). Duyuru • Aug 29
Applied UV Receives Letter from the Nasdaq Listing Qualifications Staff of the Nasdaq, Regarding Minimum Closing Bid Price On August 23, 2023, Applied UV, Inc. received a letter from the Nasdaq Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) therein stating that for the 30 consecutive business day period between July 12, 2023 through August 22, 2023, the common stock of the Company had not maintained a minimum closing bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided an initial period of 180 calendar days, or until February 20, 2024 (the “Compliance Period”), to regain compliance with the Bid Price Rule. If the Company does not regain compliance with the Bid Price Rule by February 20, 2024, the Company may be eligible for an additional 180-day period to regain compliance. To qualify, the Company would be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the Bid Price Rule, and would need to provide written notice of its intention to cure the bid price deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If the Company cannot regain compliance during the Compliance Period or any subsequently granted compliance period, the common stock of the Company will be subject to delisting. At that time, the Company may appeal the delisting determination to a Nasdaq hearings panel. The notice from Nasdaq has no immediate effect on the listing of the Company's common stock and its common stock will continue to be listed on The Nasdaq Capital Market under the symbol AUVI." The Company is currently evaluating its options for regaining compliance. There can be no assurance that the Company will regain compliance with the Bid Price Rule or maintain compliance with any of the other Nasdaq continued listing requirements. Duyuru • Aug 19
Applied UV, Inc. to Report Q2, 2023 Results on Aug 21, 2023 Applied UV, Inc. announced that they will report Q2, 2023 results Pre-Market on Aug 21, 2023 Duyuru • Aug 17
Applied UV, Inc. announced delayed 10-Q filing On 08/15/2023, Applied UV, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Duyuru • Jun 17
Applied UV, Inc. has completed a Follow-on Equity Offering. Applied UV, Inc. has completed a Follow-on Equity Offering.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 5,000,000
Price\Range: $1
Security Name: Pre-Funded Warrants
Security Type: Equity Warrant New Risk • Jun 10
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 53% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$10m free cash flow). Share price has been highly volatile over the past 3 months (17% average weekly change). Shareholders have been substantially diluted in the past year (53% increase in shares outstanding). Market cap is less than US$10m (US$7.04m market cap). Minor Risk Currently unprofitable and not forecast to become profitable next year (US$10m net loss next year). Duyuru • May 19
Applied UV, Inc. to Report Q1, 2023 Results on May 22, 2023 Applied UV, Inc. announced that they will report Q1, 2023 results After-Market on May 22, 2023 Duyuru • May 16
Applied UV, Inc. announced delayed 10-Q filing On 05/15/2023, Applied UV, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Major Estimate Revision • Apr 06
Consensus revenue estimates increase by 66%, EPS downgraded The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast increased from US$24.4m to US$40.5m. EPS estimate fell from -US$0.63 to -US$0.71 per share. Building industry in the US expected to see average net income growth of 3.4% next year. Consensus price target of US$2.50 unchanged from last update. Share price fell 2.3% to US$0.80 over the past week. Duyuru • Jan 27
Applied UV, Inc. (NasdaqCM:AUVI) acquired Puro Lighting, LLC from Brian Stern, Andrew Lawrence, Jeff Stern, Bobby Lawrence and James Colantoni for $15.1 million. Applied UV, Inc. (NasdaqCM:AUVI) entered into an agreement to acquire Puro Lighting, LLC from Brian Stern, Andrew Lawrence, Jeff Stern, Bobby Lawrence and James Colantoni for $15.1 million on December 19, 2022. Applied UV will pay $1.5 million in cash, 2.5 million shares in common stock and 0.25 million shares of Series C Preferred Stock. Breaching Party will pay to the non-Breaching Party a termination fee of $2 million. The transaction is subject to approval of PURO and Applied Board and lock-up agreement. The transaction has been approved by board of directors of both parties. Perkins Coie LLP acted as counsel to Puro.
Applied UV, Inc. completed the acquisition of Puro Lighting, LLC from Brian Stern, Andrew Lawrence, Jeff Stern, Bobby Lawrence and James Colantoni on January 26, 2023. Major Estimate Revision • Nov 21
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 revenue forecast increased from US$19.0m to US$20.7m. Forecast EPS reduced from -US$0.73 to -US$0.85 per share. Building industry in the US expected to see average net income growth of 11% next year. Consensus price target of US$5.00 unchanged from last update. Share price was steady at US$0.99 over the past week. Reported Earnings • Nov 16
Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Third quarter 2022 results: US$0.24 loss per share (further deteriorated from US$0.14 loss in 3Q 2021). Revenue: US$5.88m (up 65% from 3Q 2021). Net loss: US$3.06m (loss widened 132% from 3Q 2021). Revenue exceeded analyst estimates by 31%. Earnings per share (EPS) missed analyst estimates by 33%. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 3.0% growth forecast for the Building industry in the US. Price Target Changed • Nov 16
Price target decreased to US$5.00 Down from US$7.90, the current price target is an average from 2 analysts. New target price is 415% above last closing price of US$0.97. Stock is down 81% over the past year. The company is forecast to post a net loss per share of US$0.73 next year compared to a net loss per share of US$0.86 last year. Board Change • Nov 16
Less than half of directors are independent There are 6 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 6 new directors. 2 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). Founder, President & Director Max Munn is the most experienced director on the board, commencing their role in 2020. Independent Director Gene Burleson was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Major Estimate Revision • Aug 22
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 revenue forecast increased from US$16.4m to US$19.0m. EPS estimate fell from -US$0.64 to -US$0.73 per share. Building industry in the US expected to see average net income growth of 13% next year. Consensus price target of US$6.80 unchanged from last update. Share price fell 7.4% to US$1.82 over the past week. Reported Earnings • Aug 17
Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Second quarter 2022 results: US$0.26 loss per share (down from US$0.23 loss in 2Q 2021). Revenue: US$5.91m (up 213% from 2Q 2021). Net loss: US$3.25m (loss widened 52% from 2Q 2021). Revenue exceeded analyst estimates by 61%. Earnings per share (EPS) missed analyst estimates by 66%. Over the next year, revenue is forecast to grow 19%, compared to a 8.8% growth forecast for the Building industry in the US. Price Target Changed • Aug 12
Price target decreased to US$6.80 Down from US$7.90, the current price target is an average from 3 analysts. New target price is 251% above last closing price of US$1.94. Stock is down 74% over the past year. The company is forecast to post a net loss per share of US$0.65 next year compared to a net loss per share of US$0.86 last year. Board Change • Aug 12
Less than half of directors are independent There are 6 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 6 new directors. 2 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). Founder, President & Director Max Munn is the most experienced director on the board, commencing their role in 2020. Independent Director Gene Burleson was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.